Otros idiomas MacroGenics, Inc.

Acciones

MGNX

US5560991094

Biotecnología e investigación médica

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 22/07/2026			Variación 5 días	Varia. 1 de enero.
4,300 ^USD	-5,29 %		+0,23 %	+167,08 %

08/07	MacroGenics anuncia la dimisión de Karen Ferrante como consejera, efectiva a partir del 1 de septiembre de 2026	CI
02/07	MacroGenics cierra la venta de sus plantas de fabricación a Bora Pharmaceuticals	MT

Otros idiomas

08/07	Macrogenics, Inc. Announces Resignation of Karen Ferrante from Director Role, Effective September 1, 2026
02/07	MacroGenics Closes Sale of Manufacturing Operations to Bora Pharmaceuticals
02/07	MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals ROCKVILLE, MD, July 02, 2026 (GLOBE NEWSWIRE) MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, and Bora Pharmaceuticals Co., Ltd. (TWSE: 6472; OTCQX: BORAY), a global leader in
02/07	MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
02/07	Bora Biologics USA, LLC completed the acquisition of Good Manufacturing Practice Drug Substance Manufacturing Operations of MacroGenics, Inc..
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell Small Cap Comp Growth Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 2500 Growth Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 2000 Index
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 2000 Value Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 2000 Growth Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 3000E Index
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 3000E Growth Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 3000E Value Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 2000 Dynamic Index
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 3000 Value Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell Small Cap Completeness Index
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 3000 Growth Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 2500 Index
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell Small Cap Comp Value Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 2500 Value Benchmark
29/06	MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell 3000 Index
22/06	MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment
22/06	MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
22/06	MacroGenics Receives Regulatory Milestone Payment From Sanofi Following FDA Accelerated Approval Of TZIELD To Delay Decline In Endogenous Insulin Production In Children Aged Eight To 17 Years With Stage 3 Type 1 Diabetes
14/05	MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum